Advisory Alpha, LLC Crispr Therapeutics Ag Transaction History

Advisory Alpha, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$79.67 - $173.23 $15,934 - $34,646	-200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $15,700 - $20,128	200 New	200 $20,000
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $7,700 - $15,210	-200 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$40.99 - $52.56 $8,198 - $10,512	200 New	200 $8,000
Q2 2019 Aug 16, 2019	SELL	$35.45 - $48.2 $7,090 - $9,640	-200 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$28.02 - $40.87 $5,604 - $8,173	200 New	200 $0

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.61B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Advisory Alpha, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Alpha, LLC with notifications on news.